Cary Street Partners Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-260
Closed -$30.2K 245
2023
Q1
$30.2K Hold
260
0.01% 270
2022
Q4
$29.4K Hold
260
0.01% 296
2022
Q3
$21K Buy
+260
New +$22K 0.01% 279

Other funds holding DXCM

Cary Street Partners Asset Management's DXCM Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of DexCom (DXCM) in Q2 2023, closing a stake of 260 shares — an estimated $30.2K sold.

Cary Street Partners Asset Management first reported a position in DXCM in Q3 2022 and held it in 3 quarters. The position peaked at $30.2K in Q1 2023. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 260 DexCom shares in Q2 2023, an estimated $30.2K.
  • Cary Street Partners Asset Management first reported a position in DexCom in Q3 2022 and held it in 3 quarters.
  • Cary Street Partners Asset Management's DexCom position peaked at $30.2K in Q1 2023.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.